Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 65 of 144 pages ‹ First < 63 64 65 66 67 > Last ›
HSL9127
Alonso-zaldivar R .
Drug makers set lobbying record
Los Angeles Times 2007 Apr 3
http://articles.latimes.com/2007/apr/03/nation/na-lobby3
HSL9133
Bristol-Myers Gets FTC Document Request
Associated Press 2007 Apr 3
http://biz.yahoo.com/ap/070403/bristol_myers_squibb_ftc.html?.v=2
HSL9284
Pfizer Unit Pleads Guilty, Prosecutors Praise the Corporate Criminal, Not the Whistleblower
Corporate Crime Reporter 2007 Apr 3
http://www.corporatecrimereporter.com/pfizer040307.htm
HSL9110
Senator the Hon Brett Mason - Parliamentary Secretary to the Minister for Health and Ageing
New therapeutic products exposure Bill released
Commonwealth of Australia Department of Health and Ageing 2007 Apr 2
http://www.health.gov.au/internet/ministers/publishing.nsf/Content/mr-yr07-cp-mas003.htm
HSL9114
Herper M.
Celebrex Ads To Return
Forbes.com 2007 Apr 2
http://www.forbes.com/2007/04/01/pfizer-arthritis-vioxx-biz-sci-cz_mh_0402celebrex.html?partner=yahootix
HSL9115
Soule A.
Feds join suit against Boehringer Ingelheim
Fairfield County Business Journal 2007 Apr 2
http://www.fairfieldcbj.com/archive/040207/0402070002.php
HSL9118
Vedantam S.
Criteria for Depression Are Too Broad, Researchers Say
Washington Post 2007 Apr 2A02
http://www.washingtonpost.com/wp-dyn/content/article/2007/04/02/AR2007040201693.html
HSL9120
Pierson R.
Pfizer to pay $35 mln in Genotropin settlements
Reuters 2007 Apr 2
http://www.reuters.com/article/health-SP/idUSWNAS544720070402
HSL9122
Rubin R.
Pfizer enlists doctors to defend Lipitor
USA Today 2007 Apr 2
http://www.usatoday.com/news/health/2007-04-02-pfizer-lipitor_N.htm
HSL9126
Edwards J, Ebenkamp B.
FTC May Go After Celeb Endorsements
Brandweek 2007 Apr 2
http://www.brandweek.com/bw/news/packaged/article_display.jsp?vnu_content_id=1003566021
HSL9262
Ferreira-Gonzalez I, Busse JW, Heels-Ansdell D, Montori VM, Akl EA, Bryant DM, Alonso-Coello P, Alonso J, Worster A, Upadhye S, Jaeschke R, Schunemann HJ, Permanyer-Miralda G, Pacheco-Huergo V, Domingo-Salvany A, Wu P, Mills EJ, Guyatt GH.
Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.
BMJ 2007 Apr 2;
http://www.bmj.com/cgi/rapidpdf/bmj.39136.682083.AEv1?eaf
HSL9283
Lavoie D.
Pfizer subsidiaries agree to pay $34.7M
Associated Press 2007 Apr 2
http://www.abcmoney.co.uk/news/02200749968.htm
HSL9855
Hensley S.
Pfizer’s Kindler Speaks, Briefly
The Wall Street Journal Health Blog 2007 Apr 2
http://blogs.wsj.com/health/2007/04/02/pfizers-kindler-speaks-briefly/?mod=yahoo_hs
HSL10077
Cheng AC, Robinson PM, Harvey K.
Off-label use of medicines: consensus recommendations for evaluating appropriateness.
Med J Aust 2007 Apr 2; 186:(7):379-80
http://www.mja.com.au/public/issues/186_07_020407/letters_020407_fm-2.html
HSL9113
Kroft S.
Under The Influence
CBS News 2007 Apr 1
http://www.cbsnews.com/stories/2007/03/29/60minutes/main2625305.shtml
HSL9117
Price JH.
Spending on psychotherapeutic drugs soars
The Washington Times 2007 Apr 1
http://www.washingtontimes.com/national/20070401-120128-5227r.htm
HSL9121
Schmit J.
Pfizer to resume airing ads for Celebrex
USA Today 2007 Apr 1
http://www.usatoday.com/money/industries/health/drugs/2007-04-01-celebrex-usat_N.htm?csp=34
HSL9279
Brownlee S.
Feeding the Cancer Machine
New York Times 2007 Apr 1
http://www.nytimes.com/2007/04/01/opinion/01brownlee.html?ex=1176177600&en=7bc65522b5b5a8df&ei=5070
HSL9809
Abel GA, Lee SJ, Weeks JC.
Direct-to-consumer advertising in oncology: a content analysis of print media.
J Clin Oncol 2007 Apr 1; 25:(10):1267-71
http://jco.ascopubs.org/cgi/content/full/25/10/1267
HSL10078
Young D.
Regulators, groups engage in user fee debate.
Am J Health Syst Pharm 2007 Apr 1; 64:(7):684,
http://www.ajhp.org/cgi/content/full/64/7/684
HSL11460
Arguello B, Fernandez-Llimos F.
[Professionals' access to drug package inserts].
Aten Primaria 2007 Apr 1; 39:(4):219
http://www.doyma.es/cgi-bin/wdbcgi.exe/doyma/mrevista.fulltext?pident=13100849
HSL8677
Littman BH, Di Mario L, Plebani M, Marincola FM.
What's next in translational medicine?
Clin Sci (Lond) 2007 Apr; 112:(4):217-27
http://www.clinsci.org/cs/112/0217/cs1120217.htm
HSL9128
Gallagher R.
Companies, You're on Notice
The Scientist 2007 Apr
http://www.the-scientist.com/article/home/52948/
HSL9132
Cassels A.
Defying your drug regimen - the do's and dont's
Common Ground 2007 Apr
http://commonground.ca/iss/0704189/cg189_drugs.shtml
HSL9166
Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, Stephenson H, Schatzberg AF.
Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
Arch Gen Psychiatry 2007 Apr; 64:(4):466-72
http://archpsyc.ama-assn.org/cgi/content/full/64/4/466
HSL9172
Mackenzie FJ, Jordens CF, Ankeny RA, McPhee J, Kerridge IH.
Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia.
Intern Med J 2007 Apr; 37:(4):224-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2006.01298.x
HSL9360
Singer E.
Aggressive drug marketing tactics trigger backlash.
Nat Med 2007 Apr; 13:(4):393
http://www.nature.com/doifinder/10.1038/nm0407-393
HSL10003
Shankar PR, Subish P.
Disease mongering.
Singapore Med J 2007 Apr; 48:(4):275-80
http://smj.sma.org.sg/4804/4804ra1.pdf
HSL10016
Strauss JF 3rd, Chaudhuri G.
The accelerated pace of pharma abandonment of research and development in family planning and fertility: will reproductive health technology be frozen in time?
Fertil Steril 2007 Apr; 87:(4):717-8
http://linkinghub.elsevier.com/retrieve/pii/S0015-0282(06)04382-2
HSL10017
Cras A, Conscience MA, Rajzbaum G, Lillo-Le Louet A, Lopez N, Tersen I, Bezie Y.
Off-label prescribing in a French hospital.
Pharm World Sci 2007 Apr; 29:(2):97-100
http://www.springerlink.com/content/h677674tk8x48572/
HSL10073
Chapman K, Kelly B, King L, Flood V.
Fat chance for Mr Vegie TV ads.
Aust N Z J Public Health 2007 Apr; 31:(2):190
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17461013&query_hl=6&itool=pubmed_DocSum
HSL10074
Mitchell P.
Price controls seen as key to Europe's drug innovations lag.
Nat Rev Drug Discov 2007 Apr; 6:(4):257-8
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17457995&query_hl=7&itool=pubmed_DocSum
HSL10075
[No authors listed].
The pricing conundrum.
Nat Rev Drug Discov 2007 Apr; 6:(4):255
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17457994&query_hl=8&itool=pubmed_DocSum
HSL10082
Weiskopf RB; Novo Nordisk.
Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo Nordisk.
Acad Emerg Med 2007 Apr; 14:(4):e71-3
http://www.aemj.org/cgi/content/full/14/4/e71
HSL10122
Pruss A, von Versen R.
[Influence of European Regulations on Quality, Safety and Availibility of Cell and Tissue Allografts in Germany.]
Handchir Mikrochir Plast Chir 2007 Apr; 39:(2):81-87
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-965134
HSL10129
[No authors listed]
Arterial 'prehypertension': a useful concept for drug companies, useless for patients
Prescrire Int. 2007 Apr; 16:(88):73-5
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17460859&query_hl=2&itool=pubmed_DocSum
HSL10133
Gressens P.
Drug companies and neuroprotection of the newborn: any hope for a love story?
Acta Paediatr 2007 Apr; 96:(4):485-6
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1651-2227.2007.00265.x
HSL10134
The Lancet Infectious Diseases.
Tackling negative perceptions towards vaccination.
Lancet Infect Dis 2007 Apr; 7:(4):235
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(07)70057-9
HSL10136
Adeoye S, Bozic KJ.
Direct to consumer advertising in healthcare: history, benefits, and concerns.
Clin Orthop Relat Res 2007 Apr; 457:96-104:
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/BLO.0b013e31803427e6
HSL10137
Cunningham MR, Warme WJ, Schaad DC, Wolf FM, Leopold SS.
Industry-funded positive studies not associated with better design or larger size.
Clin Orthop Relat Res 2007 Apr; 457:235-41:
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/BLO.0b013e3180312057
HSL10156
Staff of the Committee on Finance
Use of Educational Grants by Pharmaceutical Manufacturers
Washington, DC: United States Senate 2007 Apr
http://web.archive.org/web/20110111193718/http://www.acme-assn.org/home/prb042507a.pdf
HSL10203
Jommi C, Paruzzolo S.
Public administration and R&D localisation by pharmaceutical and biotech companies: a theoretical framework and the Italian case-study.
Health Policy 2007 Apr; 81:(1):117-30
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(06)00112-6
HSL10556
Hansen DG, Dybdahl T, Jarbol D, Vach W.
Clinical interest: a study of the influence on general practitioners' prescribing.
Pharmacoepidemiol Drug Saf 2007 Apr; 16:(4):458-63
http://www3.interscience.wiley.com/cgi-bin/abstract/114113712/ABSTRACT?CRETRY=1&SRETRY=0
HSL10569
Borders JM.
Physicians and pharma--an unholy alliance?
J Ky Med Assoc 2007 Apr; 105:(4):177-8
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17494281&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10579
Croft AM.
A lesson learnt: the rise and fall of Lariam and Halfan.
J R Soc Med 2007 Apr; 100:(4):170-4
http://www.jrsm.org/cgi/content/full/100/4/170
HSL10580
Tormala ZL, Clarkson JJ.
Assimilation and contrast in persuasion: the effects of source credibility in multiple message situations.
Pers Soc Psychol Bull 2007 Apr; 33:(4):559-71
http://psp.sagepub.com/cgi/reprint/33/4/559
HSL10692
Acharya S.
Ethical issues in research outsourcing.
J Dent Educ 2007 Apr; 71:(4):447-8
http://www.jdentaled.org/cgi/content/full/71/4/447
HSL10695
Wayman JJ, Beall T, Thackeray R, Brown KR.
Competition: a social marketer's friend or foe?
Health Promot Pract 2007 Apr; 8:(2):134-9
http://hpp.sagepub.com/cgi/reprint/8/2/134
HSL10696
Goldman KD, Schmalz KJ.
Speech righting: presentation preparation principles for potent performances.
Health Promot Pract 2007 Apr; 8:(2):114-8
http://hpp.sagepub.com/cgi/reprint/8/2/114
HSL10697
Cambronero-Saiz B.
Pharmaceutical advertising: from prospectus to marketing.
J Epidemiol Community Health 2007 Apr; 61:(4):366
http://jech.bmj.com/cgi/content/full/61/4/366
HSL10778
Webster CS, Merry AF.
Colour coding, drug administration error and the systems approach to safety.
Eur J Anaesthesiol 2007 Apr; 24:(4):385-6
http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=522248
HSL10818
Giri BR, Shankar RP.
Disease mongers in a nation in transition?
Rural Remote Health 2007 Apr-Jun; 7:(2):621
http://www.rrh.org.au/articles/subviewnew.asp?ArticleID=621
HSL10820
Shankar RP.
Being a dispensing prescriber in rural South India.
Rural Remote Health 2007 Apr-Jun; 7:(2):717
http://www.rrh.org.au/articles/subviewnew.asp?ArticleID=717
HSL10822
Clover J, Wall J.
Marketing ideas and strategies for building upon the team physician's role.
Clin Sports Med 2007 Apr; 26:(2):253-63
http://linkinghub.elsevier.com/retrieve/pii/S0278-5919(07)00007-5
HSL10828
Sams-Dodd F.
Research & market strategy: how choice of drug discovery approach can affect market position.
Drug Discov Today 2007 Apr; 12:(7-8):314-8
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T64-4N6NHP5-2&_user=10&_coverDate=04%2F30%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=e90f57a4ce208ef3406bbb26d8556bc4
HSL10829
Proceedings of TCT: TCT Keynote Speaker Addresses conflict of interest.
J Interv Cardiol 2007 Apr; 20:(2):171-2
HSL10901
Jin CH, Villegas J.
Consumer responses to advertising on the Internet: the effect of individual difference on ambivalence and avoidance.
Cyberpsychol Behav 2007 Apr; 10:(2):258-66
http://www.liebertonline.com/doi/abs/10.1089/cpb.2006.9960
HSL10902
Cave S.
Corruption in health services.
J Health Serv Res Policy 2007 Apr; 12:(2):67-8
http://jhsrp.rsmjournals.com/content/12/2/67.full.pdf+html
HSL10903
Segal JZ.
lIlness as argumentation: a prolegomenon to the rhetorical study of contestable complaints.
Health (London) 2007 Apr; 11:(2):227-44
http://hea.sagepub.com/cgi/reprint/11/2/227
HSL10953
Hart D.
Patient information on drug therapy. A problem of medical malpractice law: between product safety and user safety.
Eur J Health Law 2007 Apr; 14:(1):47-59
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17566320&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10962
van der Meer JW, de Gier AM, van Swaaij WP, Katan MB.
Independent medical research.
Neth J Med 2007 Apr; 65:(4):124-6
http://www.zuidencomm.nl/njm/getpdf.php?id=10000164
HSL10965
Hall PE, Oehler J, Woo P, Zardo H, Chinery L, Singh JS, Jooseery SH, Essah NM.
A study of the capability of manufacturers of generic hormonal contraceptives in lower- and middle-income countries.
Contraception 2007 Apr; 75:(4):311-7
http://linkinghub.elsevier.com/retrieve/pii/S0010-7824(06)00446-X
HSL11103
Junod V.
[Two sides of advertising of pharmaceuticals: promotion and accountability].
Rev Med Suisse. 2007 Apr 25; 3:(108):1077-9
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17552261&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11133
Annual DTC Industry Check Up
: Dendrite International, Inc. 2007 Apr
http://www.pharma-mkting.com/resources/2007_DTC_Industry_Checkup.pdf
HSL11179
Mirowski P.
Johnny's in the basement, mixin' up the medicine. Review of Angell, Avorn, and Daemmrich on the modern pharmaceutical predicament.
Soc Stud Sci 2007 Apr; 37:(2):311-27
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17645149&dopt=AbstractPlus
HSL11181
Emanuel EJ.
Conflict of interest in industry-sponsored drug development.
Clin Adv Hematol Oncol 2007 Apr; 5:(4):265-7
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17607285&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11357
Peretz B.
New dental products and the dentists.
Refuat Hapeh Vehashinayim 2007 Apr; 24:(2):72
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17696066&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11458
Zizic-Borjanovic S, Jerinic M, Igic R.
Twenty five years of antismoking movement started by medical students: some further goals.
J BUON 2007 Apr-Jun; 12:(2):181-4
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17600869&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11555
Gaspar R.
Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals.
Nanomed 2007 Apr; 2:(2):143-7
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17716116
HSL11556
Bunger M.
Strategies for developing and commercializing nanobio drugs, diagnostics and devices.
Nanomed 2007 Apr; 2:(2):137-41
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17716115
HSL11709
Mendis S, Fukino K, Cameron A, Laing R, Filipe A Jr, Khatib O, Leowski J, Ewen M.
The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.
Bull World Health Organ 2007 Apr; 85:(4):279-88
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862007000400013&lng=en&nrm=iso&tlng=en
HSL11914
Velez-Arango AL, Cecilia Realpe D, Gonzaga-Valencia J, Castro-Castro AP.
[Legal action as mechanisms of protection the right to health in Manizales, Colombia].
Rev Salud Publica (Bogota) 2007 Apr-Jun; 9:(2):297-307
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0124-00642007000200013&lng=en&nrm=iso&tlng=en
HSL12008
Alevizos A, Mihas C, Mariolis A.
Advertising campaigns of sterol-enriched food. An often neglected cause of reduced compliance to lipid lowering drug therapy
Cardiovasc Drugs Ther. 2007 Apr; 21:(2):133-4. Epub 2007 Mar 15.
http://www.springerlink.com/content/j7563441g5654h62/
HSL12291
Gondim AP, Falcão CB.
[Evaluation of Brazilian online pharmacies].
Rev Saude Publica 2007 Apr; 41:(2):297-300
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89102007000200019&lng=en&nrm=iso&tlng=en
HSL12293
Woolf SH, Johnson RE, Phillips RL Jr, Philipsen M.
Giving everyone the health of the educated: an examination of whether social change would save more lives than medical advances.
Am J Public Health 2007 Apr; 97:(4):679-83
http://www.ajph.org/cgi/content/full/97/4/679
HSL12406
Arrais PS, Barreto ML, Coelho HL.
[Drug prescription and dispensing from the patient's perspective: a community-based study in Fortaleza, Ceará State, Brazil].
Cad Saude Publica 2007 Apr; 23:(4):927-37
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0102-311X2007000400020&lng=en&nrm=iso&tlng=en
HSL12702
Jaillon P.
[Controlled randomized clinical trials].
Bull Acad Natl Med 2007 Apr-May; 191:(4-5):739-56
http://www.ncbi.nlm.nih.gov/pubmed/18225427
HSL12858
Vieira FS, Zucchi P.
[Distortions to national drug policy caused by lawsuits in Brazil].
Rev Saude Publica 2007 Apr; 41:(2):214-22
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102007000200007&tlng=en&lng=en&nrm=iso
HSL13327
Roy N, Madhiwalla N, Pai SA.
Drug promotional practices in Mumbai: a qualitative study
Indian Journal of Medical Ethics 2007 Apr-Jun; 4:(2):57-61
http://www.ijme.in/152oa57.html
HSL9081
Charatan F.
Drug company payments to doctors still hard to access despite disclosure laws
BMJ 2007 Mar 31; 334:(7595):655
http://www.bmj.com/cgi/content/full/334/7595/655
HSL9082
Spurgeon D.
New York Times reveals payments to doctors by drug firms
BMJ 2007 Mar 31; 334:(7595):655
http://www.bmj.com/cgi/content/full/334/7595/655-a
HSL9083
Spurgeon D.
UK universities offer degrees in 'pseudoscience', Nature article says
BMJ 2007 Mar 31; 334:(7595):659
http://www.bmj.com/cgi/content/full/334/7595/659-d
HSL9084
Brown H.
Sweetening the pill
BMJ 2007 Mar 31; 334:(7595):664-666
http://www.bmj.com/cgi/content/full/334/7595/664
HSL9090
Weiss R.
Conflict-of-Interest Inquiry May Be Reopening at NIH
Washington Post 2007 Mar 31A18
http://www.washingtonpost.com/wp-dyn/content/article/2007/03/30/AR2007033000310.html
HSL9091
Kiong E.
Drink deficient only in Australasia, says GSK
New Zealand Herald 2007 Mar 31
http://www.nzherald.co.nz/section/1/story.cfm?c_id=1&objectid=10431847
HSL9168
Antonanzas F, Oliva J, Pinillos M, Juarez C.
Economic aspects of the new Spanish laws on pharmaceutical preparations.
Eur J Health Econ 2007 Mar 31;
http://www.springerlink.com/content/21640wn121u41012/
HSL9080
Crawford A.
New low-cost vaccine for Africa
BBC News 2007 Mar 30
http://news.bbc.co.uk/2/hi/health/6508985.stm
HSL9111
Parkinson's drug withdrawn
CBC News 2007 Mar 30
http://www.cbc.ca/health/story/2007/03/30/permax.html?ref=rss
HSL9112
Constipation drug linked to heart attack risk
Associated Press 2007 Mar 30
http://www.msnbc.msn.com/id/17873835/
HSL9116
The Hon Tony Abbott MHR - Minister for Health and Ageing
Plasma fractionation arrangements
Commonwealth of Australia Department of Health and Ageing 2007 Mar 30
http://www.health.gov.au/internet/ministers/publishing.nsf/content/mr-yr07-ta-abb025.htm
HSL9293
Curtis P.
Alzheimer's sufferers dying in drug 'scandal'
The Guardian 2007 Mar 30
http://society.guardian.co.uk/health/story/0,,2046457,00.html
HSL9294
Shocking new research: Alzheimer's patients are dying early because of controversial drugs
Alzheimer's Research Trust 2007 Mar 30
http://www.alzheimers-research.org.uk/news/article.php?type=News&id=99
HSL10694
Hessel L, Guenaneche F, Biasio LR, Di Marzo R.
Reply to 'Panico MG, Caporale V, Attena F. Adverse events following hexavalent vaccine (Hexavac): knowledge and information sources'
Vaccine 2007 Mar 30; 25:(14):2539-40
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17465039&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL9062
Geddes L.
Cancer pharmacy for the desperate and vulnerable
Short Sharp Science (New Scientist Blog) 2007 Mar 29
http://www.newscientist.com/blog/shortsharpscience/2007/03/cancer-pharmacy-for-desperate-and.html
HSL9063
Japsen B.
Pfizer, FDA talks could bring ads for Celebrex back to television
Chicago Tribune 2007 Mar 29
http://www.chicagotribune.com/business/chi-0703280672mar29,0,7139704.story?coll=chi-business-hed
HSL9064
Vollmer S.
GSK gave up on flu drug, suit says
The News & Observer (Raleigh, North Carolina) 2007 Mar 29
http://www.newsobserver.com/104/story/558639.html
HSL9074
Kroft S.
Vote On Rx Bill: Politics 'Ugliest Night'
CBS News 2007 Mar 29
http://www.cbsnews.com/stories/2007/03/29/60minutes/main2625305.shtml
HSL9079
Dementia patients dying early on sedatives - study
Reuters 2007 Mar 29
http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20070329:MTFH43755_2007-03-29_23-01-07_L29536368&type=comktNews&rpc=44
HSL9246
Cutler DM.
The demise of the blockbuster?
N Engl J Med 2007 Mar 29; 356:(13):1292-3
http://content.nejm.org/cgi/content/extract/356/13/1292
HSL9807
Schuster S.
Translating science into business.
Nature 2007 Mar 29; 446:(7135):582
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17421073&query_hl=5&itool=pubmed_DocSum
Page 65 of 144 pages ‹ First < 63 64 65 66 67 > Last ›
